ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000255.1|Pederin_1 # 797 # 1609 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.577	BGC0000255.1|Pederin_1 	797	1609	-	Loose	500	25.7942	OXA-624	28.57	3005845	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCTGAACTACCCGAAGTCGAAACTATTCGTCGAGGCATCGCCCCTTACCTGGAAGGTCAACGCGTCAACCGCGTGATCATCCGCGAGCGCCGCCTGCGCTGGCCGATCTCTGATAACTTAGATGTACGTCTGTCTGGACAACGTATTCTGAGCGTCGAGCGCCGCGCTAAGTACCTACTGCTGCGTGCTGAGGTCGGTACGTTGATCAACCACTTAGGCATGTCCGGTAGCCTGCGCCTGATCGAGAGCGGTCTACCAGCGAAACGCCATGATCATGTGGATATCGAGTTAGAGTCCGGACTGGCGTTGCGCTACACCGATCCGCGACGTTTCGGCGCACTACTCTGGAGCCAGGCGCCACTAGAGCACGAGTTGTTGCGCAACCTAGGCCCCGAGCCTTTGACCGACGCTTTCGCCGGTCAGAGGCTATTCGAGTTGTCGAGGGGTCGGAGTGTAGCGGTAAAGCCGTTCATCATGGACAACACTGTAGTGGTCGGAGTCGGCAATATCTACGCAAGCGAGGTGCTGTTTACCGCCGGCATCGATCCACGTAGATCCGCCGGGAATATTTCCAAGACGCGCTACTCGCGCTTGGCCGGTGAGATCAAGCGGATCCTGGCGAACGCCATTGAGTGTGGTGGCACCACCCTGTGCGATTTCATCGGCGGCGATGGTCAGCCTGGGTACTTCCAGCAGGAATTGTTTGTCTATGGCCGTGGTGGAGAATTCTGTAAGGCTTGCGGTGGCACCCTACGCGAGATCCGCCTAGGTCAACGTACCAGCGTGTATTGCCCGCATTGCCAACGTTAA	MPELPEVETIRRGIAPYLEGQRVNRVIIRERRLRWPISDNLDVRLSGQRILSVERRAKYLLLRAEVGTLINHLGMSGSLRLIESGLPAKRHDHVDIELESGLALRYTDPRRFGALLWSQAPLEHELLRNLGPEPLTDAFAGQRLFELSRGRSVAVKPFIMDNTVVVGVGNIYASEVLFTAGIDPRRSAGNISKTRYSRLAGEIKRILANAIECGGTTLCDFIGGDGQPGYFQQELFVYGRGGEFCKACGGTLREIRLGQRTSVYCPHCQR	MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKCSQVPAFKELARNIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKKIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKIKNKILSFALNVDIKDIKNIKIREELLNKYLANFFNNNRIKSFY	105.06	gnl|BL_ORD_ID|3880|hsp_num:0	4950			318	486	cloxacillin; oxacillin; cefalotin
BGC0000255.1|Pederin_2 # 2401 # 3156 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.489	BGC0000255.1|Pederin_2 	2401	3156	-	Loose	1300	25.409	optrA	35.42	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGTCTATCAAACGATCCAGGTTCGGTTTACATCCCCCATTTACCGTATCGAGTTGCACCGCCCGCAATCAGATAACACTCTGAATCAACTGATGATTGACGAATGCTTACATGCTCTCTCAGTCTGCACAACTCAGACTCACATCGTGGTGCTCGAAGGGTCAACCGAAGTTTTCTGTCTGGGTGCCGATTTCAACGCTCTTGCGACGGATCAGCCAGACATTCCTATCAATCCAGAACGGCTTTATGAGTTATGGGAGCAACTAGCTTATGGACCGTTCATCAGCATTGCCCATGTTCGCGGTAAAGCCAATGCCGGAGGAGTAGGTTTCACTGCAGCTTGCGACATCGTACTCGCCGATAAACGCGTAGAATTCAGTTTGTCGGAACTGCTGTTCGGATTGTTTCCAGCTTGTGTCCTACCTTTTCTGATCAGGCGTATCGGTTGGCAGAAAGCGCACTATATGACGTTAACGACCAAGGCGATTACCCTACAAAATGCCCTGGACTGGGGCTTGGTAGACGCGGCGCAAGGCGACAGTCAAGCGCTGCTGCGCAAGTACTTATTACGTTTACGGCATCTATCCAAGAGCGCAATCAGCGACTATAAGCATTATATGAACGGACTTCATCCCTTGATCAGTTCCGCTAGAAAGCAAGCAGTTGCTGCCAACCGCGAACTGTTCGACAATCCTAATAATCTTGAAAACATCTATCGCTACGCTCGTACCGGACAGTTTCCTTGGGAAGCTTAG	MVYQTIQVRFTSPIYRIELHRPQSDNTLNQLMIDECLHALSVCTTQTHIVVLEGSTEVFCLGADFNALATDQPDIPINPERLYELWEQLAYGPFISIAHVRGKANAGGVGFTAACDIVLADKRVEFSLSELLFGLFPACVLPFLIRRIGWQKAHYMTLTTKAITLQNALDWGLVDAAQGDSQALLRKYLLRLRHLSKSAISDYKHYMNGLHPLISSARKQAVAANRELFDNPNNLENIYRYARTGQFPWEA	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	38.32	gnl|BL_ORD_ID|2069|hsp_num:0	2263			939	1080	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0000255.1|Pederin_3 # 3258 # 4589 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.507	BGC0000255.1|Pederin_3 	3258	4589	-	Loose	750	129.028	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.1	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGTACAGTGATAGAAATACCACCGGCTTTCCGGTGGATGTGCAAATTTCGGGGATGGGGGTCGTTTCATCGATCGGCCATGATCTTACGACTTTCACAGTTTCGTTGGCAGAAGGCCGATCAGGCATCAGACAGCTTGATAATAGATGTTCTACTGGCATGGGCGCTACGAATATAATCGCAGGAATTGCTGATTTTAATTTCTCGTATGCTCTCGAAGTATGCACATCCATTCCTCCAACACTGAAACGAGCTGCCTTGCGTATTGCAAGGAGAGCTCCTTTTGCTATTCAGACCTGCGTGTTGTCAGCGCTGGAAGCCTGGACTACAGCACTGCTACATGATGCCCATCTATTACCAGAGAGTATCGGCCTAGTCATGGCTGGGCATAACACTACTCAGAACTATCAGTACCAATTGCACGAAGCTTTTCAGCAGGCTCCATATCACTTGTCTCCCAGGTACGCACTACAGTTCATGGATAGTTATTTACTGGGTGTTTTGAGTGAGATATTCAAAATTCGGGGTGAGGGTTTCGTTTGTGGTGGTGCTTCTGCTTCAGGGAACGTCGGGATAATCCATGGGTTACGCATGATTCAGGCCGGGATTGTGGACGCTTGCCTCGTCTGCGGGGTGACTGCGGATCTTTCTCCCATGGAGCTACAAGGCTTTAATGCCATCGGTGCCTTGGGGGGCAAGCATTTTCATGACCGAGCCGATCTGGCCTGTCGACCATTCGATACACAGCATGAAGGGTTCATTTACGGTCAGGCTTCCGCATGTCTCCTACTGGAATCTACTACCAGCGCAAAGTGCAGAGGAACTGTGGGTATGGCCAGGCTGCTAAGTGGAGCGATCAGGCTTCATGCCAGCTCATCATCTGAGCCGAATCTGGAAGGTGAGGTGCAAACGATGCGGACTGCTCTGCAACGTAGTAGCTTGGAGCCGGGTAATATTGACTACGTAAACACCCATGGCAGCTCATCGCCACTGGGTGATAAGATCGAGATGCAAGCGATCGAGCAGGTCTTTGGCGAGCATTTCCCAAATATCTGGCTCAACTCGAGCAAAGGGCTAATTGGTCATTGTCTTTACTCGGCCGGAGTAGTTGAGGTCATCGCTTCGGTAGTGCAAATGCGGCAAGGGTTCATCCATCCCTCCTTGAACCTCGACACTCCGATCAACAATCGCGCAAAGTTCAGCGGCCCGATTGCAGTTCGGCACCCAATCCACACAGCTATGAGTAATAGCTTTGGGTTCGGCGGTATCAATACCAGCGTTGTGCTGGGCAGTATCCCACAGCCCAAAAACAGCCCAAAGCAAGATCGATGA	MYSDRNTTGFPVDVQISGMGVVSSIGHDLTTFTVSLAEGRSGIRQLDNRCSTGMGATNIIAGIADFNFSYALEVCTSIPPTLKRAALRIARRAPFAIQTCVLSALEAWTTALLHDAHLLPESIGLVMAGHNTTQNYQYQLHEAFQQAPYHLSPRYALQFMDSYLLGVLSEIFKIRGEGFVCGGASASGNVGIIHGLRMIQAGIVDACLVCGVTADLSPMELQGFNAIGALGGKHFHDRADLACRPFDTQHEGFIYGQASACLLLESTTSAKCRGTVGMARLLSGAIRLHASSSSEPNLEGEVQTMRTALQRSSLEPGNIDYVNTHGSSSPLGDKIEMQAIEQVFGEHFPNIWLNSSKGLIGHCLYSAGVVEVIASVVQMRQGFIHPSLNLDTPINNRAKFSGPIAVRHPIHTAMSNSFGFGGINTSVVLGSIPQPKNSPKQDR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	106.49	gnl|BL_ORD_ID|1968|hsp_num:0	1943			399	1242	isoniazid
BGC0000255.1|Pederin_4 # 4579 # 4821 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.449	BGC0000255.1|Pederin_4 	4579	4821	-	Loose	2000	21.9422	oqxB	39.13	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCAGAGAAAGAATATTCAATGTGATAGCGAGAAATACGCTTGAAGTCCTTCCTGATATTCAGCCGGAAGCGATATCCACCCTCAAGAGTCTAGCTGAGCTAGGGGCCAACTCAGTCGATAGAATGGAAATAATTACCCTGTCCATGGCAGAACTGGGGGTCACGATTCCTTTGGTTAGCTTTGCAACAGTAAGCAATATCGAAGGTTTGGTCGATACACTCAGCCAGTATGTACAGTGA	MIRERIFNVIARNTLEVLPDIQPEAISTLKSLAELGANSVDRMEIITLSMAELGVTIPLVSFATVSNIEGLVDTLSQYVQ	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	7.62	gnl|BL_ORD_ID|2152|hsp_num:0	2400			894	963	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000255.1|Pederin_5 # 5045 # 6052 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.433	BGC0000255.1|Pederin_5 	5045	6052	+	Loose	550	33.4982	RlmA(II)	25.29	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTCTATATCCGCACCTGATTTTGTAGGCTTGCTAAAACAGCGTCTGCTGGATAATATTTCGACACAGATAGACCATGTTTTTAATGTGCCTGCCGATATACAAAAGATGCTGGGCGGCAGTGAGAAAAATCTGTCATTGGAAGAGAGCGCGAAGATATTCGATGCCGGCATTGTGGAACTGATGCGGAAACCAGAAGAGGATTCTTCTAAAGAAGGAGGCTCATCTTTCATTAGTCATGTAAATAACCATTACGATCATGTATTTTATGACGATAATGGAATGACGGGAGTGTTATTCGGTGATACAGACTATCGGAATCACGGCTACTGGGATAGAAATACCGTTTCTCAAGATCAAGCATGCCGGCAATTGCAAGAAATACTGCTTGACTTCATCCCAGTGAAAACAGGAAAAATTTTAGACGTCGCGTGTGGAATGGGGGCTTCTACTCGTCATCTGCTTAAATACTATCCAGCCGAGAATATATGGGCTATCAATATTTCGGATAAACAGATCGATACAGCGCGCCGAAATGCACCAGGTTGCCATGTGCAGGTCATGGATGCCACGAACATGAGCTTCGCTGATGAAGCATTTGAAAATATTCTGTGCATAGAAGCTGCCTTCCATTTTAACACGCGGCGCAAGTTCTTAGAGGAGGCTTTACGTATCCTCAAACCTGGTGGAAGGGTGGTGTTGTCGGATTTTATCTTCAGCTCACCTGAACGACTGGAGCAAAATAATATACTTCCTGGCCCAGTCAATCATCTAGCGTCAATTGAGGAATACGCTCAACTTTTGAATGACGTGGGTTTCAGCGATTTCACTATTCAAGACGTAAGTGATGAGGTTTGGGGCGGACAGTTCCTGAATGGTACGAGCAAGCTGCATAAAGCATTTTACGATGGTAAGCTTGATATCGTTCGCATGACTGAAGCACTATGGTGTTATTACTATATAAATGCTTCTACCGAAAAGAGCCTTTTCGTATCTGCACAAAAATGA	MSISAPDFVGLLKQRLLDNISTQIDHVFNVPADIQKMLGGSEKNLSLEESAKIFDAGIVELMRKPEEDSSKEGGSSFISHVNNHYDHVFYDDNGMTGVLFGDTDYRNHGYWDRNTVSQDQACRQLQEILLDFIPVKTGKILDVACGMGASTRHLLKYYPAENIWAINISDKQIDTARRNAPGCHVQVMDATNMSFADEAFENILCIEAAFHFNTRRKFLEEALRILKPGGRVVLSDFIFSSPERLEQNNILPGPVNHLASIEEYAQLLNDVGFSDFTIQDVSDEVWGGQFLNGTSKLHKAFYDGKLDIVRMTEALWCYYYINASTEKSLFVSAQK	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	118.79	gnl|BL_ORD_ID|2052|hsp_num:0	2274			285	546	tylosin; mycinamicin
BGC0000255.1|Pederin_6 # 6157 # 7575 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.431	BGC0000255.1|Pederin_6 	6157	7575	+	Loose	500	29.261	OXA-493	28.0	3005726	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGTGGCCTCCATCTATTATAAATTCCATCGCCTCTATGATCCACTTGCGGAAGTTCTACAGGCTTTTATATGTCGAGTCAGAAACTGGAATGAAGTAATTAATTTTAACGTGAGGAAGACTATTATGCCAGTTGGGATTGAAGCGATGAACCTATATGGTGGCAGTGCTTTCGTAGATGTCATGGAATTAGCAGTATATCGTAAACATGATCTTTCACGTTTCGACAATCTGTTAATGAAGCAGAAAACCGTTGCACTTCCCTATGAAGATTCAGTGAGTTTCGCTATTAATGCTGCGCAACCGTTGATAGACACTTTGTCGGAGACTGAAAAGGAGCGTATCGAGTTATTGATCACGTGTTCGGAATCAGGGATAGATTTCGGGAAATCCATAAGTACTTATATTCATCATTATTTAGGACTCAATCGTAACTGTCGGCTTTTTGAATTGAAACAAGCGTGCTACTCTGGTACTGCGGGATTGCAAATGGCAGTCAATTTCATCGTGTCAAAGGTATCTCCAGGTGCCAAGGCGCTGGTGATCGCTAGTGATCTATCGAGGTTTCTGGTCACGCGAGACGAGGAGGGAGAGTTGACTATGGATTGGGATTTTTTTGAGCCTAGCGGTGGGGCTGGTGCAATAGCCATGCTTGTCAGCGAGAAGCCCGATATATTTGAGCTAGATATTGGGGCAAACGGGTACTACACCTATGAGGTAATGGATACTTGCCGACCAATTGCGGATAGCGAAGCGGGTAACGCTGATCTATCACTTCTTTCCTATTTGGATTGCTGTGATCAGAGCTTTAAAGAGTATAAGAAACGAGTTTTTAAAGTGGATTACTGTGACACATTTCAATATCTATGCTTCCATACACCTTTTGGCGGAATGGTGAAAGGGGCGCATCGCAACATGATGCGCAAGTATAGCGATTTATCGCGTGAGGCTATTGAGGCAGATTTTCAACAGAGGGTGCAACCTGGCCTTACCTATTGCCAACGTGTCGGTAATATCATGGGTGGCACAATAATGCTTTCTTTGGCCAGCACTATTGATAACGCTATTATGAGGAATACCTGTAGAGTTGGTTGCTTTTCATATGGATCAGGCTGTTGTTCGGAATTCTACAGTGGTGTTGTGTCACCCTCAGGGCAAGCCAAACTTAGAGATTGGGCACTTGGTAAACACCTAGATAGTCGGCATAGGTTAACTATGGAGCAGTATGAAATAGTGCTTCAGCGTAGCGAGCTGGTGAAATTTGGAACTCGTAATGTTGTGCTGTCGAATGATCTAATCCCTGGCGCCTGGAAAACCATAACTCGTAATGTGCGAGAGAATAAAGATATAGATATAGGCAAAAGAATTTTTCTATCGGAAATCAAAGAATTTCATCGCCATTATGAATGGATTGAGTAG	MVASIYYKFHRLYDPLAEVLQAFICRVRNWNEVINFNVRKTIMPVGIEAMNLYGGSAFVDVMELAVYRKHDLSRFDNLLMKQKTVALPYEDSVSFAINAAQPLIDTLSETEKERIELLITCSESGIDFGKSISTYIHHYLGLNRNCRLFELKQACYSGTAGLQMAVNFIVSKVSPGAKALVIASDLSRFLVTRDEEGELTMDWDFFEPSGGAGAIAMLVSEKPDIFELDIGANGYYTYEVMDTCRPIADSEAGNADLSLLSYLDCCDQSFKEYKKRVFKVDYCDTFQYLCFHTPFGGMVKGAHRNMMRKYSDLSREAIEADFQQRVQPGLTYCQRVGNIMGGTIMLSLASTIDNAIMRNTCRVGCFSYGSGCCSEFYSGVVSPSGQAKLRDWALGKHLDSRHRLTMEQYEIVLQRSELVKFGTRNVVLSNDLIPGAWKTITRNVRENKDIDIGKRIFLSEIKEFHRHYEWIE	MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTFKIFNALIALNEGVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIGLEKMQKNLNKLNYGNQKISKIDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVINIIKLKENDHYELFAKTGWGLRQYGQIVGFIKSKKSDKIYAFALNMNISDFNKLYLREEIVQLYLDQL	190.32	gnl|BL_ORD_ID|3761|hsp_num:0	4831			441	738	cloxacillin; oxacillin; cefalotin
BGC0000255.1|Pederin_7 # 7576 # 8520 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.480	BGC0000255.1|Pederin_7 	7576	8520	+	Loose	200	24.6386	FosA4	35.9	3003210	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGAGTTGCTTGTTGGGTCTATAGGTCTAGTCTTCTTGACGATACTGATAGTTTTGTTGTGTATAGCCGTCGCCTTTTATTTGATTGCGCCAGGTTTATTGCTGGACTCCTTTCTTGCTTTGGGGCGCTGGCATGCGGGACTAAAGCGTCGGGAATCAACCTTGGATATGGTCAATTGGGTATGGCTCGATAGCGGTGGAGAGGGAGATGTTATTGTTCTCATACATGGTTTCGCTGCACATAAATATGGGTGGCTACAGGTAGCGAGCCGATTGAGGGGACGAGGTTACCGATTGATTATTCCCGATTTGCCGGGCTTTGGTGAAAATCAGGTGTCTGCCGACATAAGTTACAGTGTTTTGGAGCAGGCACAACGACTCCAGACGTTTTTGGCATCGTTGGGTATAAATAGATTTCATGCTGTCGGGCATTCGATGGGTGGATATGTGGCGGGGGCATGTGCGTTTATTGACTCTGATATGCTGCTTAGTCTTTATCTTGTCGCACCCGCCGGTATTACGGTGGAAGGGGAGCCAATAGATTTGTCAGAGAAAGGTAAGAAGAATAACTTATTTATCATCGAAACGGTGGAGCAATTCCAGGAGGTCATGGCAATCGCTATGGCAAATCCTCCGAAGCTCCCTCGTCGGATAGTGGAGTCGATGGTTGCGAGGGAGCTTACAATGCGTAAGCTGCGAGAAAAGCAGAATGAGGTTTGGGACTCTCCCTCTTTACAGCGACTACTGTCGAATTGTTCAATTCCTTTACGCATGCTGTGGGGCGAGCGAGATCGCATGTTATCTGTTGATAGAGCAGCTTTGATTGTAGAGGCCGTTCCCATGGCTAGCATCAGGTATCTTCCTGATATAGCACACGTCATTCCCCAAGAAGCACCGAGTGTAATGGTCCGGGATTATCTGATTTCATTGCTGCTCTCCCATTAG	MELLVGSIGLVFLTILIVLLCIAVAFYLIAPGLLLDSFLALGRWHAGLKRRESTLDMVNWVWLDSGGEGDVIVLIHGFAAHKYGWLQVASRLRGRGYRLIIPDLPGFGENQVSADISYSVLEQAQRLQTFLASLGINRFHAVGHSMGGYVAGACAFIDSDMLLSLYLVAPAGITVEGEPIDLSEKGKKNNLFIIETVEQFQEVMAIAMANPPKLPRRIVESMVARELTMRKLREKQNEVWDSPSLQRLLSNCSIPLRMLWGERDRMLSVDRAALIVEAVPMASIRYLPDIAHVIPQEAPSVMVRDYLISLLLSH	MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLAQRLAACRERPYKGMVFFD	227.54	gnl|BL_ORD_ID|1828|hsp_num:0	1979			9	111	fosfomycin
BGC0000255.1|Pederin_8 # 8547 # 9440 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.480	BGC0000255.1|Pederin_8 	8547	9440	-	Loose	550	100.908	NmcR	31.51	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGTTCGCGAACGTACCTTTGACCTCATTGAGGTCTTTCGAGTCAGCAGCCAGGCTTGGCAGTTTCAAGGCTGCTGCGGCAGAGCTTTCAGTCACAGCCTCCGCTGTTTCACACCAAATCAAATCTTTAGAAAGTAAACTCGGCGTCCTATTATTCCACCGCCAGGCAAAAGGTGTAGAGCTTACCCCACCGGGTTTCAATTTATACAACGAAACTCACCAATATTTCTCAAATCTCAGCTCCAGTCTAGACCAATTACGTCCTCGTGTGGATAGCAAGGTGCTAACAGTAACCACCACTCATGCATTTACGGCGTTATGGCTAATACCTAGAATCGGCGATTTCTATCGACACTACCCCGACATAAAAGTTAACATAATAACAAGCAACGTTTTGATAGACCTGCACCGAAACTCTACCATTGATCTCGGCATTCGAGGTCTATTCCAGCAAGAAGCAAGTACCTATCAACTTCATTTAATGGACGAATATTTCAAAGTCTATATGCCTTACCATCGCAATCCGTCAGAAGACACGCATCGGCAATTAATCAATGTCCGCTGGGAACCAAGAGCGCAGGGTCCCTTCGACTGGCCCACATGGTGCAAGGCTGCTGGGCATGAAGATTGGTTGGAACATGCGATTTTAAGAGAGTATGACGATGAGCACTATGCCGTACAGGCGGCCATCTCTGGCTACGGCATGGTGCTTGCCAGCAATGTGCTGACAGCGGAATATGTAGCCAAAGGCACCTTGAGCCCTTACAAGCCTGAAATTAAATTACCGGGTGCCCGTTATGTGGCAGCCTGCATCCCAGGTAGAGAGCGACACTTACCAGTCAAACGCTTCCTCGACTGGCTCGTTCATGAAGCTTCAAGGCACGTTAACGAGTAA	MFANVPLTSLRSFESAARLGSFKAAAAELSVTASAVSHQIKSLESKLGVLLFHRQAKGVELTPPGFNLYNETHQYFSNLSSSLDQLRPRVDSKVLTVTTTHAFTALWLIPRIGDFYRHYPDIKVNIITSNVLIDLHRNSTIDLGIRGLFQQEASTYQLHLMDEYFKVYMPYHRNPSEDTHRQLINVRWEPRAQGPFDWPTWCKAAGHEDWLEHAILREYDDEHYAVQAAISGYGMVLASNVLTAEYVAKGTLSPYKPEIKLPGARYVAACIPGRERHLPVKRFLDWLVHEASRHVNE	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	100.68	gnl|BL_ORD_ID|1905|hsp_num:0	2072			0	624	cefoxitin; cefazolin; ampicillin
